Disulfiram has been shown to markedly inhibit dopamine-β-hydroxylase in vivo and to result in a decrease in norepinephrine content of tissues, presumably by making β-hydroxylation rate limiting. Disulfiram also inhibits the β-hydroxylation of tyramine to octopamine. While β-hydroxylation of tyramine appears to be necessary for retention by sympathetic vesicles, dopamine can be retained by the vesicles when β-hydroxylation is inhibited.
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Pharmacology, Toxicology and Pharmaceutics(all)